Issue 14, 2023, Issue in Progress

Zirconium ferrite incorporated zeolitic imidazolate framework-8: a suitable photocatalyst for degradation of dopamine and sulfamethoxazole in aqueous solution

Abstract

The complete removal of pharmaceutical wastes from polluted water systems is a global challenge. Therefore, this study incorporates zirconium ferrite (ZrFe2O4) into zeolitic imidazolate framework-8 (ZIF-8) to form ZrFe2O4@ZIF-8. The ZrFe2O4@ZIF-8 is a photocatalyst for removing dopamine (DOP) and sulfamethoxazole (SMX) from an aqueous solution. The scanning electron micrograph revealed the surfaces of ZrFe2O4 and ZrFe2O4@ZIF-8 to be heterogeneous with irregularly shaped and sized particles. The transmission electron micrograph (TEM) images of ZrFe2O4 and ZrFe2O4@ZIF-8 showed an average particle size of 24.32 nm and 32.41 nm, respectively, with a bandgap of 2.10 eV (ZrFe2O4@ZIF-8) and 2.05 eV (ZrFe2O4). ZrFe2O4@ZIF-8 exhibited a better degradation capacity towards DOP and SMX than ZrFe2O4. ZrFe2O4@ZIF-8 expressed a complete (100%) degradation of DOP and SMX during the photodegradation process. Interestingly, the process involved both adsorption and photocatalytic degradation simultaneously. ZrFe2O4@ZIF-8 demonstrated high stability with a consistent regeneration capacity of 98.40% for DOP and 94.00% for SMX at the 10th cycle of treatment in a process described by pseudo-first-order kinetics. The study revealed ZrFe2O4@ZIF-8 as a promising photocatalyst for the purification of DOP and SMX-contaminated water systems.

Graphical abstract: Zirconium ferrite incorporated zeolitic imidazolate framework-8: a suitable photocatalyst for degradation of dopamine and sulfamethoxazole in aqueous solution

Supplementary files

Article information

Article type
Paper
Submitted
15 Feb 2023
Accepted
19 Mar 2023
First published
23 Mar 2023
This article is Open Access
Creative Commons BY license

RSC Adv., 2023,13, 9563-9575

Zirconium ferrite incorporated zeolitic imidazolate framework-8: a suitable photocatalyst for degradation of dopamine and sulfamethoxazole in aqueous solution

A. Adewuyi, O. A. Ogunkunle and R. A. Oderinde, RSC Adv., 2023, 13, 9563 DOI: 10.1039/D3RA01055D

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements